| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.356 | 0.003 | 0.356 | Acetylcholine release stimulant | 0.113 0.06 CID_154699534 | ||
| 0.31 | 0.045 | 0.405 | Vasodilator | 0.405 0.022 CID_154699534 | CID_154699534 | |
| 0.271 | 0.024 | 0.271 | Cholinergic | |||
| 0.356 | 0.144 | 0.356 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.308 | 0.128 | 0.308 | MAP kinase kinase 6 inhibitor | |||
| 0.171 | 0.002 | 0.171 | Nitric oxide donor | 0.129 0.003 CID_154699534 | ||
| 0.239 | 0.092 | 0.239 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.151 | 0.008 | 0.151 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.155 | 0.015 | 0.155 | CYP2A6 inhibitor | |||
| 0.219 | 0.098 | 0.219 | Superoxide dismutase inhibitor | |||
| 0.124 | 0.005 | 0.124 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.167 | 0.058 | 0.167 | NOS3 expression enhancer | 0.162 0.062 CID_154699534 | ||
| 0.122 | 0.025 | 0.122 | Acetylcholine nicotinic agonist | |||
| 0.123 | 0.029 | 0.123 | Acetylcholine nicotinic antagonist | |||
| 0.136 | 0.044 | 0.136 | 5 Hydroxytryptamine 3A agonist | |||
| 0.108 | 0.021 | 0.108 | Neuronal nicotinic receptor antagonist | |||
| 0.095 | 0.009 | 0.095 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.086 | 0.015 | 0.086 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.074 | 0.009 | 0.074 | Glycine transporter 1 inhibitor | |||
| 0.063 | 0.004 | 0.063 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.078 | 0.022 | 0.078 | Nicotinic neuronal receptor agonist | |||
| 0.194 | 0.139 | 0.194 | MAP kinase kinase 3 inhibitor | |||
| 0.214 | 0.161 | 0.26 | Vasodilator, peripheral | 0.26 0.12 CID_154699534 | CID_154699534 | |
| 0.179 | 0.13 | 0.179 | Nitric-oxide synthase stimulant | |||
| 0.048 | 0.005 | 0.048 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.067 | 0.026 | 0.067 | Nicotinic alpha7 receptor agonist | |||
| 0.223 | 0.181 | 0.223 | Calcium channel activator | |||
| 0.053 | 0.014 | 0.053 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.068 | 0.033 | 0.068 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.189 | 0.156 | 0.189 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.146 | 0.12 | 0.153 | Psychostimulant | 0.153 0.114 CID_154699534 | CID_154699534 | |
| 0.085 | 0.06 | 0.085 | Acetylcholine agonist | |||
| 0.028 | 0.005 | 0.028 | Nicotinic alpha4 receptor agonist | |||
| 0.048 | 0.026 | 0.048 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.082 | 0.063 | 0.082 | mTOR complex 2 inhibitor | |||
| 0.032 | 0.017 | 0.032 | DNA topoisomerase IV inhibitor | |||
| 0.122 | 0.108 | 0.122 | Death-associated protein kinase 1 inhibitor | |||
| 0.115 | 0.103 | 0.115 | Activin receptor-like kinase 2 inhibitor | |||
| 0.256 | 0.246 | 0.284 | Caspase 9 stimulant | 0.284 0.211 CID_154699534 | CID_154699534 | |
| 0.059 | 0.05 | 0.059 | 5 Hydroxytryptamine 3 agonist | |||
| 0.041 | 0.033 | 0.041 | Nerve growth factor antagonist | |||
| 0.043 | 0.038 | 0.043 | Glycine transporter inhibitor | |||
| 0.099 | 0.097 | 0.099 | Cholinergic antagonist | |||
| 0.169 | 0.167 | 0.169 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | |||
| 0.115 | 0.116 | 0.128 | Acetylcholine M1 receptor antagonist | 0.128 0.097 CID_154699534 | CID_154699534 | |
| 0.16 | 0.184 | 0.44 | DNA synthesis inhibitor | 0.44 0.018 CID_154699534 | CID_154699534 | |
| 0.097 | 0.163 | 0.211 | Insulin secretagoues | 0.211 0.031 CID_154699534 | CID_154699534 | |
| 0.176 | 0.25 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.193 0.186 CID_154699534 | CID_154699534 | |
| 0.031 | 0.112 | 0.061 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.061 0.033 CID_154699534 | CID_154699534 | |
| 0.019 | 0.107 | 0.045 | Guanylate cyclase inhibitor | 0.045 0.026 CID_154699534 | CID_154699534 | |
| 0.019 | 0.17 | 0.083 | Argininosuccinate synthase inhibitor | 0.083 0.024 CID_154699534 | CID_154699534 | |
| 0.046 | 0.199 | 0.251 | UDP-glucose 4-epimerase inhibitor | 0.251 0.013 CID_154699534 | CID_154699534 | |
| 0.08 | 0.234 | 0.156 | DNA repair enzyme inhibitor | 0.156 0.026 CID_154699534 | CID_154699534 | |
| 0.124 | 0.294 | 0.398 | Vasodilator, coronary | 0.398 0.036 CID_154699534 | CID_154699534 | |
| 0.062 | 0.233 | 0.362 | Angiogenesis stimulant | 0.362 0.029 CID_154699534 | CID_154699534 | |
| 0.11 | 0.287 | 0.303 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.303 0.023 CID_154699534 | CID_154699534 | |
| 0.099 | 0.279 | 0.248 | Cyclic AMP phosphodiesterase inhibitor | 0.248 0.065 CID_154699534 | CID_154699534 | |
| 0.019 | 0.201 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_154699534 | CID_154699534 | |
| 0.018 | 0.206 | 0.102 | Biliverdin reductase inhibitor | 0.102 0.018 CID_154699534 | CID_154699534 | |
| 0.052 | 0.244 | 0.117 | Cytidine deaminase inhibitor | 0.117 0.104 CID_154699534 | CID_154699534 | |
| 0.006 | 0.218 | 0.02 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.02 0.007 CID_154699534 | CID_154699534 | |
| 0.015 | 0.231 | 0.113 | Phosphofructokinase-1 inhibitor | 0.113 0.027 CID_154699534 | CID_154699534 | |
| 0.126 | 0.343 | 0.458 | Antibacterial | 0.458 0.054 CID_154699534 | CID_154699534 | |
| 0.039 | 0.264 | 0.12 | Alkylator | 0.12 0.068 CID_154699534 | CID_154699534 | |
| 0.04 | 0.27 | 0.127 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.127 0.035 CID_154699534 | CID_154699534 | |
| 0.029 | 0.273 | 0.097 | Glutamate dehydrogenase inhibitor | 0.097 0.032 CID_154699534 | CID_154699534 | |
| 0.061 | 0.309 | 0.185 | Interleukin agonist | 0.185 0.135 CID_154699534 | CID_154699534 | |
| 0.125 | 0.376 | 0.279 | Interleukin 2 agonist | 0.279 0.09 CID_154699534 | CID_154699534 | |
| 0.05 | 0.312 | 0.106 | Adenylate kinase inhibitor | 0.106 0.059 CID_154699534 | CID_154699534 | |
| 0.038 | 0.321 | 0.096 | NADH dehydrogenase inhibitor | 0.096 0.048 CID_154699534 | CID_154699534 | |
| 0.093 | 0.388 | 0.197 | RNA-directed DNA polymerase inhibitor | 0.197 0.104 CID_154699534 | CID_154699534 | |
| 0.086 | 0.383 | 0.248 | Antithrombotic | 0.248 0.128 CID_154699534 | CID_154699534 | |
| 0.023 | 0.33 | 0.115 | Histone deacetylase SIRT1 stimulant | 0.115 0.02 CID_154699534 | CID_154699534 | |
| 0.023 | 0.33 | 0.115 | Histone deacetylase stimulant | 0.115 0.02 CID_154699534 | CID_154699534 | |
| 0.071 | 0.385 | 0.233 | Transcription factor NF kappa B inhibitor | 0.233 0.14 CID_154699534 | CID_154699534 | |
| 0.004 | 0.347 | 0.041 | Adenosine A1 receptor agonist | 0.041 0.007 CID_154699534 | CID_154699534 | |
| 0.017 | 0.372 | 0.099 | Expectorant | 0.099 0.07 CID_154699534 | CID_154699534 | |
| 0.033 | 0.439 | 0.107 | Aldehyde dehydrogenase inhibitor | 0.107 0.086 CID_154699534 | CID_154699534 | |
| 0.077 | 0.521 | 0.25 | Apoptosis antagonist | 0.25 0.128 CID_154699534 | CID_154699534 | |
| 0.012 | 0.466 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 CID_154699534 | CID_154699534 | |
| 0.024 | 0.511 | 0.23 | Immunostimulant | 0.23 0.105 CID_154699534 | CID_154699534 | |
| 0.027 | 0.535 | 0.23 | DNA methyltransferase I inhibitor | 0.23 0.055 CID_154699534 | CID_154699534 | |
| 0.026 | 0.567 | 0.237 | DNA methylase inhibitor | 0.237 0.056 CID_154699534 | CID_154699534 | |
| 0.019 | 0.573 | 0.17 | Free radical scavenger | 0.17 0.123 CID_154699534 | CID_154699534 | |
| 0.003 | 0.583 | 0.03 | Purinergic P2X agonist | 0.03 0.017 CID_154699534 | CID_154699534 | |
| 0.075 | 0.658 | 0.35 | Peptidyltransferase inhibitor | 0.35 0.012 CID_154699534 | CID_154699534 | |
| 0.008 | 0.667 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.061 0.03 CID_154699534 | CID_154699534 | |
| 0.03 | 0.694 | 0.205 | Hepatoprotectant | 0.205 0.062 CID_154699534 | CID_154699534 | |
| 0.012 | 0.682 | 0.154 | Platelet antagonist | 0.154 0.14 CID_154699534 | CID_154699534 | |
| 0.006 | 0.746 | 0.19 | Topoisomerase I inhibitor | 0.19 0.029 CID_154699534 | CID_154699534 | |
| 0.017 | 0.784 | 0.22 | Immunosuppressant | 0.22 0.177 CID_154699534 | CID_154699534 | |
| 0.019 | 0.802 | 0.213 | Hypoglycemic | 0.213 0.101 CID_154699534 | CID_154699534 | |
| 0.02 | 0.858 | 0.078 | Transcription factor NF kappa B stimulant | 0.078 0.075 CID_154699534 | CID_154699534 | |
| 0.005 | 0.847 | 0.159 | Antioxidant | 0.159 0.154 CID_154699534 | CID_154699534 | |
| 0.013 | 0.856 | 0.238 | Apoptosis agonist | 0.238 0.228 CID_154699534 | CID_154699534 | |
| 0.003 | 0.861 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.009 CID_154699534 | CID_154699534 | |
| 0.001 | 0.889 | 0.017 | Purinergic receptor agonist | 0.017 0.009 CID_154699534 | CID_154699534 | |
| 0.001 | 0.889 | 0.017 | Purinergic P2 agonist | 0.017 0.009 CID_154699534 | CID_154699534 | |
| 0.006 | 0.897 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 CID_154699534 | CID_154699534 | |
| 0.005 | 0.9 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 CID_154699534 | CID_154699534 | |
| 0.012 | 0.91 | 0.191 | DNA polymerase I inhibitor | 0.191 0.031 CID_154699534 | CID_154699534 | |
| 0.001 | 0.9 | 0.013 | Purinergic P2Y agonist | 0.013 0.008 CID_154699534 | CID_154699534 | |
| 0.007 | 0.931 | 0.195 | Immunomodulator | 0.195 0.171 CID_154699534 | CID_154699534 | |
| 0.002 | 0.947 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.009 CID_154699534 | CID_154699534 | |
| 0.006 | 0.958 | 0.139 | Platelet adhesion inhibitor | 0.139 0.119 CID_154699534 | CID_154699534 | |
| 0.008 | 0.979 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 CID_154699534 | CID_154699534 | |
| 0.005 | 0.978 | 0.266 | Cyclophilin D inhibitor | 0.266 0.195 CID_154699534 | CID_154699534 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |